CTOs on the Move

Respicardia

www.respicardia.com

 
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve Respiratory Rhythm Management and cardiovascular health. The remedē® System is an innovative implantable stimulation device designed to restore natural breathing during sleep for patients with Central Sleep Apnea.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.respicardia.com
  • 12400 Whitewater Dr Suite 150
    Minnetonka, MN USA 55343
  • Phone: 952.540.4470

Executives

Name Title Contact Details

Funding

Respicardia raised $58.5M on 12/19/2017

Similar Companies

Cordis

With more than a 60-year history of pioneering products to treat millions of patients, Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technology. Cordis established a legacy of high-quality and minimally-invasive cardiovascular products; and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2, 2021, Cordis is a standalone company, and is committed to investing $300 million to accelerate innovation in its broad product portfolio. Building on our storied brand, we are unleashing our potential to be a $10 billion leader bringing new technology to the market through bold action at speed.

Advanced Diabetes Supply

Advanced Diabetes Supply provides diabetes testing supplies to people nationwide. Our highly trained staff and state of the art technology ensures fast and convenient home delivery anywhere in the country.

Caire

CAIRE, Inc. is the leading respiratory care products provider for the home health care market. We manufacture a full line of Liquid Oxygen Reservoirs and Liquid Oxygen Portables. CAIRE combines product expertise and consulting to bring a unique approach

Evergreen Research

Evergreen Research Corporation has performed contract product development with an emphasis on medical devices since 1988. Evergreen Research offers a complete range of development services from product definition and feasibility studies through detailed design to pilot-run and low-volume production.Their experience and resourceful staff, seasoned program management, and knowledge of regulations ensure customer satisfaction and compliance with regulatory requirements. Evergreen Research, Inc. also known as ERI, has developed advanced electromechanical and software-based products providing a complete range of development services, such as product requirements definition, project planning, risk management, comprehensive design expertise (electrical, mechanical, software and industrial), design documentation, verification and validation, clinical studies, regulatory approvals, production quality planning and much more. Evergreen Research Advantages include highly skilled electrical, mechanical, and software engineers, on-site regulatory and quality expertise, manufacturing capability to build prototypes and marketed products such as Therapeutic Devices, Diagnostic Systems, Medical Software and Medical Imaging products.

XII Medical

Minimally Invasive Technology for Obstructive Sleep Apnea